NASDAQ: ARTL
Artelo Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARTL

Based on 2 analysts offering 12 month price targets for Artelo Biosciences Inc

Min Forecast
$5.00+334.78%
Avg Forecast
$5.50+378.26%
Max Forecast
$6.00+421.74%

Should I buy or sell ARTL stock?

Based on 2 analysts offering ratings for Artelo Biosciences Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARTL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARTL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ARTL stock forecasts and price targets.

ARTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-14
lockedlocked$00.00+00.00%2024-12-09

1 of 1

Forecast return on equity

Is ARTL forecast to generate an efficient return?

Company
N/A
Industry
151.81%
Market
68.86%

Forecast return on assets

Is ARTL forecast to generate an efficient return on assets?

Company
N/A
Industry
22.99%

ARTL earnings per share forecast

What is ARTL's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.07

ARTL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARTL$1.15$5.50+378.26%Strong Buy
NBY$0.73N/AN/A
INM$4.95N/AN/A
SLRX$2.69N/AN/A
ATXI$1.85N/AN/A

Artelo Biosciences Stock Forecast FAQ

Is Artelo Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ARTL) stock is to Strong Buy ARTL stock.

Out of 2 analysts, 1 (50%) are recommending ARTL as a Strong Buy, 1 (50%) are recommending ARTL as a Buy, 0 (0%) are recommending ARTL as a Hold, 0 (0%) are recommending ARTL as a Sell, and 0 (0%) are recommending ARTL as a Strong Sell.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.

What is ARTL's earnings growth forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 20.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 25.22%.

Artelo Biosciences's earnings in 2025 is -$9,121,000.

In 2025, ARTL is forecast to generate -$3,453,639 in earnings, with the lowest earnings forecast at -$5,196,597 and the highest earnings forecast at -$1,710,681.

What is ARTL's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ARTL) forecast ROE is N/A, which is considered weak.

What is ARTL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ARTL price target, the average ARTL price target is $5.50, with the highest ARTL stock price forecast at $6.00 and the lowest ARTL stock price forecast at $5.00.

On average, Wall Street analysts predict that Artelo Biosciences's share price could reach $5.50 by Jan 14, 2026. The average Artelo Biosciences stock price prediction forecasts a potential upside of 378.26% from the current ARTL share price of $1.15.

What is ARTL's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's current Earnings Per Share (EPS) is -$2.87. In 2025, ARTL's EPS is forecast to hit -$1.07 (min: -$1.61, max: -$0.53).

What is ARTL's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ARTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.99%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.